Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online April 3, 2008
Stem Cells Vol. 26 No. 8 August 2008, pp. 1931 -1938
doi:10.1634/stemcells.2007-1002; www.StemCells.com
© 2008 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2007-1002v1
26/8/1931    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fong, H.
Right arrow Articles by Donovan, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fong, H.
Right arrow Articles by Donovan, P. J.

EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS

Regulation of Self-Renewal and Pluripotency by Sox2 in Human Embryonic Stem Cells

Helen Fonga,b,c, Kristi A. Hohensteina,b,c,d, Peter J. Donovana,b,c

aSue and Bill Gross Stem Cell Research Program and
Departments of bDevelopmental and Cell Biology and
cBiological Chemistry, University of California, Irvine, Irvine, California, USA;
dHuman Genetics and Molecular Biology Training Program, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Key Words. Human embryonic stem cells • RNA interference • Sox2 • Oct4 • Nanog • Differentiation • Self-renewal • Pluripotency

Correspondence: Correspondence: Peter J. Donovan, Ph.D., 2501 Hewitt Hall, University of California, Irvine, California 92697, USA. Telephone: 949-824-3691; Fax: 949-824-6388; e-mail: pdonovan{at}uci.edu

Received on December 18, 2007; accepted for publication on March 18, 2008.

First published online in STEM CELLS EXPRESS  April 3, 2008.


Human embryonic stem (hES) cells, derived from blastocysts, are capable of unlimited self-renewal and differentiation into all cell lineages of the body. Because of their pluripotent nature, hES cells are valuable tools for understanding human development and advancing the field of regenerative medicine. However, one key to harnessing the therapeutic power of hES cells for biomedical applications begins with determining how these cells maintain their pluripotent and undifferentiated state. Studies in mice have implicated three factors in regulating pluripotency in embryonic stem cells, Oct4, Nanog, and Sox2. However, significant differences in growth regulation between mouse embryonic stem and hES cells have been identified, suggesting a need to determine when and how factors work in hES cells. To date, the transcription factors Oct4 and Nanog have been identified as critical regulators of stem cell fate by functional studies in hES cells. To determine the role of Sox2 in maintaining hES cell pluripotency and self-renewal, we used RNA interference to specifically knock down Sox2 gene expression. Reduction of Sox2 expression in hES cells results in loss of the undifferentiated stem cell state, as indicated by a change in cell morphology, altered stem cell marker expression, and increased expression of trophectoderm markers. In addition, knockdown of Sox2 results in reduced expression of several key stem cell factors, including Oct4 and Nanog, linking these three factors together in a pluripotent regulatory network.

Disclosure of potential conflicts of interest is found at the end of this article.




This article has been cited by other articles:


Home page
Stem CellsHome page
R. M. R. Gangemi, F. Griffero, D. Marubbi, M. Perera, M. C. Capra, P. Malatesta, G. L. Ravetti, G. L. Zona, A. Daga, and G. Corte
SOX2 Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity
Stem Cells, January 1, 2009; 27(1): 40 - 48.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. Yu and J. A. Thomson
Pluripotent stem cell lines
Genes & Dev., August 1, 2008; 22(15): 1987 - 1997.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2008 by AlphaMed Press.